Pulse nav.journalClub Tendências Explorar Perguntas Pesquisadores

Download the App

Join discussions, follow papers, and never miss your next session.

© Synapse Social LLC, 2026Política de privacidade

Início Explorar nav.journalClub Tendências

⌘+K

August 31, 2023Open Access

Single-Dose Psilocybin Treatment for Major Depressive Disorder

Key Points

Key points are not available for this paper at this time.

Abstract

ClinicalTrials.gov Identifier: NCT03866174.

Like

Bookmark

Share

View Full Paper

Like

Bookmark

Share

View Full Paper

Cite This Study

Raison et al. (Thu,) studied this question.

synapsesocial.com/papers/69de918140ea06567955831c https://doi.org/https://doi.org/10.1001/jama.2023.14530

Single-Dose Psilocybin Treatment for Major Depressive Disorder | Synapse

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The measurement of disability1996 · 1,421 citations
2Untitled2008 · 4 citations
3Untitled2021 · 4 citations
4A critical review of pharmacotherapy for major depressive disorder2011 · 63 citations
5Human hallucinogen research: guidelines for safety2008 · 1,178 citations